Latest News
These funds have low fees and solid diversification, which can make them great investments to buy and hold.
Via The Motley Fool · November 29, 2025
Most travel cards hand you an annual hotel credit that's basically free money, but almost no one remembers to use it.
Via The Motley Fool · November 29, 2025
Is Fluor stock your best bet to profit from the nuclear renaissance? It certainly looks cheap enough.
Via The Motley Fool · November 29, 2025
This mining company is poised to become the U.S.'s go-to supplier for rare earth magnets.
Via The Motley Fool · November 29, 2025
Both of these stocks have underperformed in 2025. But they could crush the market in 2026 and beyond.
Via The Motley Fool · November 29, 2025
MarketBeat Week in Review – 11/24 - 11/28marketbeat.com
Via MarketBeat · November 29, 2025
Silver price reached a fresh all-time high on Friday amid concerns over China’s inventories.
Via Talk Markets · November 29, 2025
Discover ATAT stock, a high-growth pick with strong earnings momentum and a bullish technical setup poised for a potential breakout.
Via Chartmill · November 29, 2025
Some 0% intro APR cards offer up to 21 months of no interest. Here's how paying just $285 a month can knock out $6,000 in credit card debt.
Via The Motley Fool · November 29, 2025
Opendoor has outperformed the S&P 500 recently, but this could soon change in a big way.
Via The Motley Fool · November 29, 2025
Discover Intuit (INTU), an affordable growth stock with strong earnings, solid profitability, and reasonable valuation for risk-adjusted returns.
Via Chartmill · November 29, 2025
Novo Nordisk (NVO) is a top dividend stock with a 3.71% yield, strong earnings, and a history of reliable dividend growth, offering dependable income.
Via Chartmill · November 29, 2025
The Shiller CAPE ratio is flashing warning signs.
Via The Motley Fool · November 29, 2025
XRP spot ETFs saw $643.92 million in net inflows in their debut month, reaching $676.49 million in total assets.
Via Talk Markets · November 29, 2025
DRDGOLD (DRD) aligns with Peter Lynch's GARP strategy, showing strong EPS growth, minimal debt, high profitability, and an attractive PEG ratio under 1.0.
Via Chartmill · November 29, 2025
The pharma stock yields more than 4x the S&P 500 average.
Via The Motley Fool · November 29, 2025
Lemonade (LMND) stock meets Mark Minervini's strict Trend Template with strong technicals and accelerating fundamental growth in revenue and earnings.
Via Chartmill · November 29, 2025
Since 2023, these stocks have soared between 490% and 2,400%.
Via The Motley Fool · November 29, 2025
Wall Street is bullish on Nvidia's stock.
Via The Motley Fool · November 29, 2025
Nasdaq price prediction based on the technical analysis.
Via Talk Markets · November 29, 2025
Oracle is one of the biggest names in enterprise software and cloud services. They power databases used by governments, banks, hospitals, airlines, and global corporations.
Via Talk Markets · November 29, 2025
These funds offer yields that are more than three times the S&P 500 average.
Via The Motley Fool · November 29, 2025
Catalyst Pharmaceuticals offers strong growth, solid profitability, and a debt-free balance sheet, all at an attractive valuation compared to its biotech peers.
Via Chartmill · November 29, 2025
AEP stock shows strong technicals and a high-quality breakout setup, trading near 52-week highs with defined entry and stop levels.
Via Chartmill · November 29, 2025
Discover the catalysts that could ignite CrowdStrike's next big move and see why analysts believe the stock still has major upside.
Via The Motley Fool · November 29, 2025